Eli Lilly’s obesity and diabetes treatments fuel growth and spark bidding war

U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, ...

Eli Lilly, Walmart partner to bring Zepbound to customers with direct-to-consumer pricing

Eli Lilly and Company and Walmart have announced a partnership to offer Zepbound single-dose vials at Walmart pharmacies. The ...

Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development

It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it ...
Houston Public Media

Eli Lilly announces weight-loss drug to be manufactured at $6.5 billion site in Houston

A sign for Eli Lilly and Company sits outside its corporate headquarters in Indianapolis on April 26, 2017. Pharmaceutical corporation Eli Lilly and Company plans to build a $6.5 billion ...
Medical Dialogues

Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal

In a move aimed at expanding access to obesity and diabetes care in India, Eli Lilly and Company (India) Pvt. Ltd. (Lilly) ...
Fierce Pharma

Eli Lilly teams up with basketball legend Shaquille O'Neal to take sleep apnea awareness campaign to new heights

In its mission to enlighten others to the symptoms of obstructive sleep apnea (OSA), Eli Lilly is getting an assist from NBA ...
BioSpace

J&J, Lilly Crest AI Wave With Nvidia Partnerships

Eli Lilly and Johnson & Johnson are joining fellow Big Pharma peers in upping their investment in AI, with Lilly looking to ...